Although groups representing 340B providers will be measured in any public statements, they are elated by the Democratic sweep of the two U.S. Senate races in Georgia on Tuesday. With Raphael Warnock (D) and Jon Ossoff’s (D) victories,
Chicago Tribune’s front page article yesterday about drug manufacturers’ denials of 340B pricing on medications dispensed by contract pharmacies got the attention of U.S. Senate Democratic Whip *** Durbin (Ill.) and Illinois Gov. J.B. Pritzker (D).
UPDATE Jan. 5, 2021 2:30 p.m. EST—Shortly after we published today’s issue, Pharmaceutical Research and Manufacturers of America (PhRMA) responded to our request for comment on the U.S. Health and Human Services (HHS) General Counsel’s Dec. 30 advisory